vTv Therapeutics Inc. (VTVT)
Largest Insider Buys in Sector
VTVT Stock Price History Chart
VTVT Stock Performance
About vTv Therapeutics Inc.
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule …
Insider Activity of vTv Therapeutics Inc.
Over the last 12 months, insiders at vTv Therapeutics Inc. have bought $83,812 and sold $0 worth of vTv Therapeutics Inc. stock.
On average, over the past 5 years, insiders at vTv Therapeutics Inc. have bought $2.59M and sold $100,050 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SEKHRI PAUL J (Pres, CEO and Exec Chairperson) — $167,624.
The last purchase of 1,844 shares for transaction amount of $31,269 was made by SEKHRI PAUL J (Pres, CEO and Exec Chairperson) on 2024‑11‑18.
List of Insider Buy and Sell Transactions, vTv Therapeutics Inc.
| 2024-11-18 | Pres, CEO and Exec Chairperson | 1,844 0.058% | $16.96 | $31,269 | -6.76% | |||
| 2024-11-15 | Pres, CEO and Exec Chairperson | 3,156 0.1377% | $16.65 | $52,543 | -10.52% | |||
| 2022-11-29 | director | 40,461 0.0852% | $0.83 | $33,773 | -9.63% | |||
| 2022-11-28 | director | 20,539 0.0431% | $0.83 | $16,969 | -8.98% | |||
| 2021-12-20 | Sale | director | 87,000 0.154% | $1.15 | $100,050 | -26.54% | ||
| 2021-02-26 | director | 60,000 0.1142% | $2.86 | $171,600 | -31.58% | |||
| 2021-02-26 | director | 10,000 0.0182% | $2.74 | $27,400 | -31.58% | |||
| 2020-12-17 | director | 625,000 0.9225% | $1.60 | $1M | -2.36% | |||
| 2020-12-10 | director | 625,000 0.893% | $1.60 | $1M | -4.79% | |||
| 2020-11-24 | director | 625,000 1.0514% | $1.60 | $1M | +13.44% | |||
| 2020-05-15 | director | 10,000 0.022% | $3.00 | $30,000 | -22.48% | |||
| 2020-05-12 | director | 625,000 0.8555% | $1.60 | $1M | -8.98% | |||
| 2020-02-25 | director | 1.25M 1.438% | $1.60 | $2M | -33.44% | |||
| 2020-01-28 | director | 1.25M 2.1109% | $1.60 | $2M | -2.29% | |||
| 2020-01-07 | director | 1.25M 2.5998% | $1.60 | $2M | +20.34% | |||
| 2019-12-18 | director | 1.37M 4.3437% | $1.46 | $2M | +40.13% | |||
| 2019-11-26 | director | 1.37M 4.4914% | $1.46 | $2M | +42.86% | |||
| 2019-11-12 | director | 1.37M 4.3437% | $1.46 | $2M | +38.16% | |||
| 2019-10-24 | director | 1.37M 4.2053% | $1.46 | $2M | +33.76% | |||
| 2019-09-26 | director | 1.37M 4.3232% | $1.46 | $2M | +45.83% |